Coherus Oncology, Inc.
US ˙ NasdaqGM ˙ US19249H1032

SecurityCHRS / Coherus Oncology, Inc.
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership194,405 shares
Latest Disclosed Value $ 328,544
Squarepoint Ops LLC reports 109.59% increase in ownership of CHRS / Coherus Oncology, Inc.

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 194,405 shares of Coherus Oncology, Inc. (US:CHRS) valued at $328,544 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 92,756 shares of Coherus Oncology, Inc.. This represents a change in shares of 109.59% during the quarter. The current value of the position is $285,775 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F COHERUS ONCOLOGY COM 19249H103 194,405 101,649 109.59 329 150.38 0.0004
2026-02-13 2025-12-31 13F COHERUS ONCOLOGY COM 19249H103 92,756 92,756 132 0.0001
2025-11-14 2025-09-30 13F COHERUS ONCOLOGY COM 19249H103 0 -41,058 -100.00 0 -100.00
2025-08-27 2025-06-30 13F/A-1 COHERUS ONCOLOGY COM 19249H103 41,058 41,058 30 0.0000
2025-08-14 2025-06-30 13F COHERUS ONCOLOGY COM 19249H103 41,058 41,058 30 0.0000
2024-11-14 2024-09-30 13F COHERUS BIOSCIENCES COM 19249H103 0 -10,214 -100.00 0 -100.00
2024-08-14 2024-06-30 13F COHERUS BIOSCIENCES COM 19249H103 10,214 -57,364 -84.89 18 -89.44 0.0000
2024-05-15 2024-03-31 13F COHERUS BIOSCIENCES COM 19249H103 67,578 -93,547 -58.06 162 -69.96 0.0003
2024-02-14 2023-12-31 13F COHERUS BIOSCIENCES COM 19249H103 161,125 161,125 537 0.0010
2023-11-14 2023-09-30 13F COHERUS BIOSCIENCES COM 19249H103 0 -285,338 -100.00 0 -100.00
2023-08-14 2023-06-30 13F COHERUS BIOSCIENCES COM 19249H103 285,338 197,489 224.81 1,218 103.00 0.0037
2023-05-15 2023-03-31 13F COHERUS BIOSCIENCES COM 19249H103 87,849 54,284 161.73 601 126.42 0.0024
2023-02-14 2022-12-31 13F COHERUS BIOSCIENCES COM 19249H103 33,565 -38,946 -53.71 266 -61.98 0.0011
2022-11-14 2022-09-30 13F COHERUS BIOSCIENCES COM 19249H103 72,511 72,511 697 0.0035
2021-11-15 2021-09-30 13F COHERUS BIOSCIENCES COM 19249H103 0 -116,257 -100.00 0 -100.00
2021-08-16 2021-06-30 13F COHERUS BIOSCIENCES COM 19249H103 116,257 116,257 1,608 0.0061
2021-05-17 2021-03-31 13F COHERUS BIOSCIENCES COM 19249H103 0 -22,254 -100.00 0 -100.00
2021-02-16 2020-12-31 13F COHERUS BIOSCIENCES COM 19249H103 22,254 22,254 387 0.0029
2020-11-16 2020-09-30 13F COHERUS BIOSCIENCES COM 19249H103 0 -16,280 -100.00 0 -100.00
2020-08-14 2020-06-30 13F COHERUS BIOSCIENCES COM 19249H103 16,280 -90,085 -84.69 291 -83.13 0.0047
2020-05-15 2020-03-31 13F COHERUS BIOSCIENCES COM 19249H103 106,365 13,841 14.96 1,725 3.54 0.0441
2020-02-14 2019-12-31 13F COHERUS BIOSCIENCES COM 19249H103 92,524 62,683 210.06 1,666 175.37 0.0099
2019-11-14 2019-09-30 13F COHERUS BIOSCIENCES COM 19249H103 29,841 -49,732 -62.50 605 -65.61 0.0054
2019-08-14 2019-06-30 13F COHERUS BIOSCIENCES COM 19249H103 79,573 4,184 5.55 1,759 71.11 0.0171
2019-05-15 2019-03-31 13F COHERUS BIOSCIENCES COM 19249H103 75,389 75,389 -5.26 1,028 -41.56 0.0109
2019-02-14 2018-12-31 13F COHERUS BIOSCIENCES COM 19249H103 0 -20,780 -100.00 0 -100.00
2018-11-14 2018-09-30 13F COHERUS BIOSCIENCES COM 19249H103 20,780 20,780 343 0.0041
2018-05-15 2018-03-31 13F COHERUS BIOSCIENCES COM 19249H103 0 -23,032 -100.00 0 -100.00
2018-02-14 2017-12-31 13F COHERUS BIOSCIENCES COM 19249H103 23,032 6,740 41.37 203 -6.45 0.0035
2017-11-14 2017-09-30 13F COHERUS BIOSCIENCES COM 19249H103 16,292 -47,278 -74.37 217 -76.21 0.0042
2017-08-14 2017-06-30 13F COHERUS BIOSCIENCES COM 19249H103 63,570 53,711 544.79 912 336.36 0.0179
2017-05-15 2017-03-31 13F COHERUS BIOSCIENCES COM 19249H103 9,859 9,859 -84.49 209 -77.08 0.0058
2016-05-16 2016-03-31 13F COHERUS BIOSCIENCES COM 19249H103 0 -10,700 -100.00 0 -100.00
2016-02-16 2015-12-31 13F COHERUS BIOSCIENCES COM 19249H103 10,700 10,700 246 0.0270
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.